Principal Investigator - Dr. Shahin Lockman MD, MPH
Study Objectives
Primary Objectives
- To evaluate the safety and tolerability of VRC01 mAb administered through IV infusion in sub-Saharan African women.
- To determine if the VRC01 mAb prevents HIV-1 infection and to estimate the level of efficacy in sub-Saharan African women.
Study Design: Multicenter, randomized, controlled, double-blind trial.